# SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study

> **NCT07198191** · — · ACTIVE_NOT_RECRUITING · sponsor: **Yonsei University** · enrollment: 200000 (estimated)

## Conditions studied

- Acute Myocardial Infarction (AMI)
- Type 2 Diabetes Mellitus (T2DM)

## Interventions

- **DRUG:** SGLT2 inhibitors (e.g., dapagliflozin, empagliflozin)
- **DRUG:** DPP4 inhibitors

## Key facts

- **NCT ID:** NCT07198191
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-09-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2026-08-30
- **Target enrollment:** 200000 (ESTIMATED)
- **Last updated:** 2025-09-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07198191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07198191, "SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07198191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*